| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 90.39B | 92.30B | 90.51B | 84.01B | 82.91B | 74.87B |
| Gross Profit | 28.81B | 28.12B | 28.09B | 25.55B | 26.57B | 23.43B |
| EBITDA | 13.83B | 13.28B | 17.48B | 14.61B | 13.13B | 12.65B |
| Net Income | 6.69B | 7.39B | 9.06B | 7.10B | 7.07B | 6.38B |
Balance Sheet | ||||||
| Total Assets | 125.76B | 129.88B | 128.16B | 135.63B | 121.68B | 118.96B |
| Cash, Cash Equivalents and Short-Term Investments | 29.02B | 27.76B | 31.58B | 35.85B | 35.31B | 34.71B |
| Total Debt | 5.05B | 2.00B | 5.67B | 6.42B | 8.94B | 4.74B |
| Total Liabilities | 31.72B | 28.26B | 32.37B | 37.38B | 34.08B | 32.08B |
| Stockholders Equity | 94.04B | 101.62B | 95.79B | 98.25B | 87.60B | 86.88B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.54B | 758.00M | 6.88B | 3.74B | 2.99B |
| Operating Cash Flow | 0.00 | 10.31B | 7.75B | 11.93B | 9.34B | 9.04B |
| Investing Cash Flow | 0.00 | -7.05B | -3.62B | -2.67B | -7.00B | -7.38B |
| Financing Cash Flow | 0.00 | -9.36B | -8.24B | -9.47B | -3.74B | -3.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥282.74B | 7.78 | 8.91% | 3.85% | 5.98% | 39.06% | |
78 Outperform | ¥90.29B | 7.87 | ― | 3.82% | 3.17% | 654.02% | |
76 Outperform | ¥93.70B | 0.96 | ― | 1.43% | 8.02% | 1762.59% | |
71 Outperform | ¥108.41B | 15.48 | ― | 4.64% | 1.98% | -17.68% | |
66 Neutral | ¥30.11B | 14.14 | ― | 2.13% | 0.12% | 59.33% | |
65 Neutral | ¥152.28B | 13.13 | ― | 3.47% | 4.99% | 20.74% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |